Table 1

 Patient characteristics according to homocysteine tertiles at baseline

T1 (n = 724)T2 (n = 734)T3 (n = 711)
*Mean (standard deviation, SD) or #median with interquartile range; †still smoking or drinking or recently stopped smoking or drinking; ‡fasting serum glucose ⩾7.0 mmol/l or self-reported diabetes.
Homocysteine, μmol/l*9.8 (SD 1.3)13.3 (SD 1.0)20.4 (SD 8.5)
Male gender, % (n)69 (503)78 (576)86 (610)
Age, years*56.8 (SD 9.8)59.3 (SD 9.8)62.8 (SD 10.4)
Body mass index, kg/m2*26.7 (SD 3.8)26.8 (SD 3.8)26.4 (SD 3.6)
Smoking†, % (n)30.9 (224)32.3 (237)34.0 (242)
Alcohol use†, % (n)73.1 (529)65.7 (482)68.5 (487)
Total cholesterol, mmol/l*5.3 (SD 1.1)5.3 (SD 1.2)5.3 (SD 1.0)
Diabetes mellitus‡, % (n)22 (161)19 (139)20 (139)
Creatinine clearance, ml/min (Cockroft)86.0 (SD 17.8)79.3 (SD 18.4)67.2 (SD 20.8)
Glucose-lowering agents, % (n)13 (96)10 (74)10 (70)
Blood pressure-lowering agents, % (n)27 (193)31 (229)41 (290)
Lipid-lowering agents, % (n)15 (110)15 (111)17 (118)
Metabolic syndrome, % (n)43.5 (315)40.5 (289)44.8 (328)
Metabolic syndrome components
    Waist circumference, cm*94.7 (SD 10.7)97.0 (SD 10.5)96.9 (SD 10.6)
    Blood pressure systolic, mm Hg*138 (SD 22)139 (SD 20)144 (SD 23)
    Blood pressure diastolic, mm Hg*80 (SD 11)80 (SD 11)81 (SD 12)
    HDL-cholesterol, mmol/l#1.16 (0.96–1.40)1.14 (0.94–1.39)1.16 (0.93–1.38)
    Triglycerides, mmol/l#1.6 (1.1–2.2)1.6 (1.1–2.2)1.6 (1.2–2.4)
    Fasting glucose, mmol/l*6.4 (SD 2.3)6.3 (SD 1.8)6.2 (SD 1.6)